Genpharmasec has informed that the Trading Window for dealing in securities of the Company by its Promoters, Members of Promoter Group, Directors, Key Managerial Persons and Designated Persons & their immediate relatives shall remain closed from Wednesday, October 01, 2025 until 48 hours after the declaration of Un-audited Financial Results of the Company for the quarter and half year ending on 30th September, 2025. Accordingly, all Insiders/Designated Persons & their immediate relatives have been advised not to trade in the Securities of the Company during the aforesaid period of closure of Trading Window. Further, date of meeting of the Board of Directors to consider and approve the Un-Audited Financial Results for the quarter and half year ending on 30th September, 2025 will be intimated in due course.
The above information is a part of company’s filings submitted to BSE.
